We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Commentary · February 06, 2021

Defining Endpoints and Biomarkers in IBD



Additional Info

Disclosure statements are available on the authors' profiles:

Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design
Gastroenterology 2020 Dec 01;159(6)2013-2018.e7, MT Abreu, WJ Sandborn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading